Literature DB >> 18388212

Can MR imaging diagnose adult-onset Alexander disease?

L Farina1, D Pareyson, L Minati, I Ceccherini, L Chiapparini, S Romano, P Gambaro, R Fancellu, M Savoiardo.   

Abstract

BACKGROUND AND
PURPOSE: In recent years, the discovery that mutations in the glial fibrillary acidic protein gene (GFAP) were responsible for Alexander disease (AD) brought recognition of adult cases. The purpose of this study was to demonstrate that MR imaging allows identification of cases of AD with adult onset (AOAD), which are remarkably different from infantile cases.
MATERIALS AND METHODS: In this retrospective study, brain and spinal cord MR imaging studies of 11 patients with AOAD (7 men, 4 women; age range, 26-64 years; mean age, 43.6 years), all but 1 genetically confirmed, were reviewed. Diffusion and spectroscopic investigations were available in 6 patients each.
RESULTS: Atrophy and changes in signal intensity in the medulla oblongata and upper cervical spinal cord were present in 11 of 11 cases and were the diagnostic features of AOAD. Minimal to moderate supratentorial periventricular abnormalities were seen in 8 patients but were absent in the 3 oldest patients. In these patients, postcontrast enhancement was also absent. Mean diffusivity was not altered except in abnormal white matter (WM). Increase in myo-inositol (mIns) was also restricted to abnormal periventricular WM.
CONCLUSIONS: Awareness of the MR pattern described allows an effective selection of the patients who need genetic investigations for the GFAP gene. This MR pattern even led to identification of asymptomatic cases and should be regarded as highly characteristic of AOAD.

Entities:  

Mesh:

Year:  2008        PMID: 18388212      PMCID: PMC8118843          DOI: 10.3174/ajnr.A1060

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  32 in total

1.  Atypical focal MRI lesions in a case of juvenile Alexander's disease.

Authors:  Eva Neumaier Probst; Christian Hagel; Vanja Weisz; Sandra Nagel; Oliver Wittkugel; Hermann Zeumer; Alfried Kohlschütter
Journal:  Ann Neurol       Date:  2003-01       Impact factor: 10.422

Review 2.  GFAP and its role in Alexander disease.

Authors:  Roy A Quinlan; Michael Brenner; James E Goldman; Albee Messing
Journal:  Exp Cell Res       Date:  2007-04-06       Impact factor: 3.905

3.  Fatal encephalopathy with astrocyte inclusions in GFAP transgenic mice.

Authors:  A Messing; M W Head; K Galles; E J Galbreath; J E Goldman; M Brenner
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Alexander disease: diagnosis with MR imaging.

Authors:  M S van der Knaap; S Naidu; S N Breiter; S Blaser; H Stroink; S Springer; J C Begeer; R van Coster; P G Barth; N H Thomas; J Valk; J M Powers
Journal:  AJNR Am J Neuroradiol       Date:  2001-03       Impact factor: 3.825

5.  Autosomal dominant palatal myoclonus and spinal cord atrophy.

Authors:  Yuji Okamoto; Hideo Mitsuyama; Manabu Jonosono; Keiko Hirata; Kimiyoshi Arimura; Mitsuhiro Osame; Masanori Nakagawa
Journal:  J Neurol Sci       Date:  2002-03-15       Impact factor: 3.181

6.  MR findings in Leigh syndrome with COX deficiency and SURF-1 mutations.

Authors:  Laura Farina; Luisa Chiapparini; Graziella Uziel; Marianna Bugiani; Massimo Zeviani; Mario Savoiardo
Journal:  AJNR Am J Neuroradiol       Date:  2002-08       Impact factor: 3.825

7.  Adult Alexander disease with autosomal dominant transmission: a distinct entity caused by mutation in the glial fibrillary acid protein gene.

Authors:  Erika Stumpf; Hélène Masson; Antoine Duquette; France Berthelet; Julia McNabb; Anne Lortie; Jacques Lesage; Jacques Montplaisir; Bernard Brais; Patrick Cossette
Journal:  Arch Neurol       Date:  2003-09

8.  Dominantly-inherited adult-onset leukodystrophy with palatal tremor caused by a mutation in the glial fibrillary acidic protein gene.

Authors:  Dominic Thyagarajan; Timothy Chataway; Rong Li; Wei Ping Gai; Michael Brenner
Journal:  Mov Disord       Date:  2004-10       Impact factor: 10.338

9.  A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate.

Authors:  Marjo S van der Knaap; Patrick van der Voorn; Frederik Barkhof; Rudy Van Coster; Ingeborg Krägeloh-Mann; Annette Feigenbaum; Susan Blaser; Johan S H Vles; Peter Rieckmann; Petra J W Pouwels
Journal:  Ann Neurol       Date:  2003-02       Impact factor: 10.422

10.  Mutations in GFAP, encoding glial fibrillary acidic protein, are associated with Alexander disease.

Authors:  M Brenner; A B Johnson; O Boespflug-Tanguy; D Rodriguez; J E Goldman; A Messing
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

View more
  36 in total

1.  MS-like presentation of Alexander disease with multifocal lesions and oligoclonal bands.

Authors:  Henriette J Tschampa; Susanne Greschus; Michael Vinahl; Horst Urbach; Marcus M Mueller; Wanda M Gerding
Journal:  J Neurol       Date:  2010-12-04       Impact factor: 4.849

2.  Late onset Alexander's disease presenting as cerebellar ataxia associated with a novel mutation in the GFAP gene.

Authors:  Stephan Schmidt; Mike P Wattjes; Wanda M Gerding; Marjo van der Knaap
Journal:  J Neurol       Date:  2010-12-17       Impact factor: 4.849

Review 3.  The clinical spectrum of late-onset Alexander disease: a systematic literature review.

Authors:  Pietro Balbi; Silvana Salvini; Cira Fundarò; Giuseppe Frazzitta; Roberto Maestri; Dibo Mosah; Carla Uggetti; GianPietro Sechi
Journal:  J Neurol       Date:  2010-08-20       Impact factor: 4.849

4.  Unusual presentations and intrafamilial phenotypic variability in infantile onset Alexander disease.

Authors:  Davide Tonduti; Anna Ardissone; Isabella Ceccherini; Giorgio Giaccone; Laura Farina; Isabella Moroni
Journal:  Neurol Sci       Date:  2016-01-07       Impact factor: 3.307

5.  Alexander disease causing mutations in the C-terminal domain of GFAP are deleterious both to assembly and network formation with the potential to both activate caspase 3 and decrease cell viability.

Authors:  Yi-Song Chen; Suh-Ciuan Lim; Mei-Hsuan Chen; Roy A Quinlan; Ming-Der Perng
Journal:  Exp Cell Res       Date:  2011-07-02       Impact factor: 3.905

6.  Identification of a novel nonsense mutation in the rod domain of GFAP that is associated with Alexander disease.

Authors:  Tai-Seung Nam; Jin Hee Kim; Chi-Hsuan Chang; Woong Yoon; Yoon Seok Jung; Sa-Yoon Kang; Boo Ahn Shin; Ming-Der Perng; Seok-Yong Choi; Myeong-Kyu Kim
Journal:  Eur J Hum Genet       Date:  2014-04-23       Impact factor: 4.246

7.  Characteristics of cerebral lesions in adult-onset Alexander disease.

Authors:  Tomokatsu Yoshida; Ikuko Mizuta; Rei Yasuda; Masanori Nakagawa; Toshiki Mizuno
Journal:  Neurol Sci       Date:  2019-08-17       Impact factor: 3.307

8.  Familial Adult-onset Alexander Disease: Clinical and Neuroradiological Findings of Three Cases.

Authors:  Ayşe Deniz Elmali; Ümran Çetinçelik; Civan Işlak; Nurten Uzun Adatepe; Feray Karaali Savrun; Cengiz Yalçinkaya
Journal:  Noro Psikiyatr Ars       Date:  2016-06-01       Impact factor: 1.339

9.  Adult polyglucosan body disease: Natural History and Key Magnetic Resonance Imaging Findings.

Authors:  Fanny Mochel; Raphael Schiffmann; Marjan E Steenweg; Hasan O Akman; Mary Wallace; Frédéric Sedel; Pascal Laforêt; Richard Levy; J Michael Powers; Sophie Demeret; Thierry Maisonobe; Roseline Froissart; Bruno Barcelos Da Nobrega; Brent L Fogel; Marvin R Natowicz; Catherine Lubetzki; Alexandra Durr; Alexis Brice; Hanna Rosenmann; Varda Barash; Or Kakhlon; J Moshe Gomori; Marjo S van der Knaap; Alexander Lossos
Journal:  Ann Neurol       Date:  2012-09       Impact factor: 10.422

Review 10.  Adult-onset Alexander disease with typical "tadpole" brainstem atrophy and unusual bilateral basal ganglia involvement: a case report and review of the literature.

Authors:  Michito Namekawa; Yoshihisa Takiyama; Junko Honda; Haruo Shimazaki; Kumi Sakoe; Imaharu Nakano
Journal:  BMC Neurol       Date:  2010-04-01       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.